CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $87.85M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 2.98: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
65.05MGBP87.85M · vs all stocks (USD)
Trailing P/E
31.83xRevenue (TTM)
87.53MGBP118.21M · vs all stocks (USD)
Profit Margin
2.50%Beta
-0.0050xvs all stocks
52-Week Change
28.63%vs all stocks
Market Capitalization
65.05MGBP87.85M · vs all stocks (USD)
Enterprise Value
52.62MGBP71.07M · vs all stocks (USD)
Trailing P/E
31.83xForward P/E
20.19xPrice to Sales (TTM)
0.7279xPrice to Book (MRQ)
0.7432xEnterprise to Revenue
0.6010xEnterprise to EBITDA
6.82xProfit Margin
2.50%Operating Margin
9.46%Return on Assets (TTM)
2.99%Return on Equity (TTM)
3.84%Revenue (TTM)
87.53MGBP118.21M · vs all stocks (USD)
Revenue per Share (TTM)
1.30GBPUpdated Jul 29, 2026Quarterly Revenue Growth
3.70%Gross Profit (TTM)
42.50MGBP57.39M · vs all stocks (USD)
EBITDA (TTM)
6.34MGBP8.56M · vs all stocks (USD)
Net Income (TTM)
2.19MGBP2.96M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.50%Operating Cash Flow (TTM)
7.66MGBP10.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.34MGBP7.21M · vs all stocks (USD)
5-Year Average Dividend Yield
2.45%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
9.27MGBPFY2025 · Mar 31, 2025Revenue
79.60MGBPFY2025 · Mar 31, 2025Cost of Goods Sold
43.68MGBPFY2025 · Mar 31, 2025Gross Profit
35.91MGBPFY2025 · Mar 31, 2025Operating Income
3.35MGBP4.52M · vs all stocks (USD)
Pre-tax Income
4.01MGBPFY2025 · Mar 31, 2025Income Tax Expense
1.38MGBPFY2025 · Mar 31, 2025Net Income
2.63MGBPFY2025 · Mar 31, 2025EBIT
4.46MGBPFY2025 · Mar 31, 2025EBITDA (Income Statement)
6.34MGBPFY2025 · Mar 31, 2025Research & Development
3.99MGBPFY2025 · Mar 31, 2025Selling, General & Administrative
28.73MGBPFY2025 · Mar 31, 2025Non-operating Interest Income
110.00KGBPFY2025 · Mar 31, 2025Non-operating Interest Expense
452.00KGBPFY2025 · Mar 31, 2025EPS (Basic)
0.0249GBPFY2025 · Mar 31, 2025EPS (Diluted)
0.0243GBPFY2025 · Mar 31, 2025Basic Shares Outstanding
67.63MSharesFY2025 · Mar 31, 2025Diluted Shares Outstanding
67.63MSharesFY2025 · Mar 31, 2025Minority Interests (P&L)
-948.00KGBPFY2025 · Mar 31, 2025Preferred Stock Dividends
0.00GBPFY2025 · Mar 31, 2025Operating Cash Flow
10.04MGBPFY2025 · Mar 31, 2025Free Cash Flow
9.69MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents (End of Period)
25.01MGBPFY2025 · Mar 31, 2025Starting Profit (CF Statement)
4.01MGBPFY2025 · Mar 31, 2025Stock-based Compensation
401.00KGBPFY2025 · Mar 31, 2025Other Non-cash Items
-612.00KGBPFY2025 · Mar 31, 2025Change in Accounts Receivable (CF)
4.16MGBPFY2025 · Mar 31, 2025Change in Other Assets/Liabilities
2.09MGBPFY2025 · Mar 31, 2025Capital Expenditures
-356.00KGBPFY2025 · Mar 31, 2025Net Intangibles (CF)
-4.65MGBPFY2025 · Mar 31, 2025Net Acquisitions
288.00KGBPFY2025 · Mar 31, 2025Net Investing Cash Flow
-68.00KGBPFY2025 · Mar 31, 2025Common Dividends Paid
-1.06MGBPFY2025 · Mar 31, 2025Net Financing Cash Flow
-1.06MGBPFY2025 · Mar 31, 2025Shares Outstanding
66.71MSharesUpdated Jul 29, 2026Float Shares
59.27MSharesUpdated Jul 29, 2026% Held by Insiders
11.81%vs all stocks
% Held by Institutions
70.57%vs all stocks
Total Cash (MRQ)
25.43MGBP34.35M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3750GBPUpdated Jul 29, 2026Total Debt (MRQ)
4.93MGBP6.66M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0517xCurrent Ratio (MRQ)
3.42xBook Value per Share (MRQ)
1.28GBPUpdated Jul 29, 2026Total Assets
120.60MGBP162.88M · vs all stocks (USD)
Total Current Assets
69.94MGBPFY2025 · Mar 31, 2025Total Liabilities
25.84MGBPFY2025 · Mar 31, 2025Total Non-current Assets
50.66MGBPFY2025 · Mar 31, 2025Total Non-current Liabilities
4.03MGBPFY2025 · Mar 31, 2025Total Current Liabilities
21.81MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents
25.01MGBPFY2025 · Mar 31, 2025Accounts Receivable
25.43MGBPFY2025 · Mar 31, 2025Inventory
14.55MGBPFY2025 · Mar 31, 2025Accounts Payable
9.79MGBPFY2025 · Mar 31, 2025Short-term Debt
621.00KGBPFY2025 · Mar 31, 2025Long-term Debt
3.16MGBPFY2025 · Mar 31, 2025Common Stock (Book)
3.39MGBPFY2025 · Mar 31, 2025Retained Earnings
17.87MGBPFY2025 · Mar 31, 2025Total Shareholders' Equity
94.77MGBP127.98M · vs all stocks (USD)
Treasury Stock
204.00KGBPFY2025 · Mar 31, 202552-Week Low
72.00GBXUpdated Jul 29, 202652-Week High
116.90GBXUpdated Jul 29, 202652-Week Change
28.63%vs all stocks
Beta
-0.0050xvs all stocks
50-Day MA
91.89GBXUpdated Jul 29, 2026200-Day MA
96.76GBXUpdated Jul 29, 2026Avg 10-Day Volume
334.84KSharesUpdated Jul 29, 2026Avg 30-Day Volume
178.52KSharesUpdated Jul 29, 2026Diluted EPS (TTM)
0.0300GBPUpdated Jul 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.98: safe zoneNotable
Altman Z-Score: 2.98
High earnings qualityNotable
Earnings Quality Score: 1.44
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $87.85M, lower than 95% of all stocks globallySignificant
Market cap (USD): 87,848,031.831Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Creo Medical Group plc
Tier 1ProductionApproval-Gated PipelineRule
Curiosis Inc.
Tier 1ProductionApproval-Gated PipelineRule
Poolbeg Pharma plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Bonus BioGroup Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Y-Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kala Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Faron Pharmaceuticals Oy
Tier 1ProductionApproval-Gated PipelineRuleRisk
Engene Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Polaryx Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nibec Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule